Location: Home
  • search
  • go
  • Relate News
  • 2/26/2026China's Healthcare Reform Playbook: Boosting Births and Opening the Do...
  • 2/25/2026The Patent Term Compensation and Protection Scope in the Compensated P...
  • 2/25/2026Global Pharma Giants Rush to License Chinese Weight-Loss Drugs, Eye Ob...
  • 2/25/2026China Outpaces US and EU in Drug R&D with Faster Trials and Lower Cost...
  • 2/25/2026Henlius Expands Global Footprint with Exclusive Abbott Licensing Deal ...
  • 2/25/2026Slate Medicines Launches With $130M to Advance China-Licensed PACAP Mi...
  • 2/25/2026Prodegre Closes Angel+ Round to Advance CNS Pipeline and ATLAS™ Platf...
  • 2/25/2026Kelun-Biotech's sac-TMT OS Data Selected as Late-Breaker at ELCC 2026
  • 2/25/2026CDE Solicits Comments on Batch 104 of Chemical Generic Reference Formu...
  • 2/25/2026CASI Pharma to Be Delisted from Nasdaq, Shares to Move to OTC Market
  • 2/25/2026CStone Secures UK Approval for Sugemalimab in Stage III NSCLC
  • 2/25/2026China Schedules Antitrust Hearing in Abuse‑of‑Dominance Case Tied to...
  • 2/24/2026Pfizer Acquires China Rights to Sciwind's Approved GLP-1 Therapy
  • 2/24/2026United Labs and Novo Nordisk Post Strong Phase 2 Data for UBT251 Tripl...
  • 2/24/2026XtalPi and YolTech Forge AI Alliance to Advance mRNA and In Vivo CAR-T...
  • 2/24/2026Frontier Biotech Inks Global siRNA Licensing Deal with GSK
  • 2/24/2026Harbour BioMed Strikes $1.1B-Plus Ex-China Deal for Anti-CTLA-4 Antibo...
  • 2/24/2026Ascentage Registers U.S. Phase 1 Trial for BTK PROTAC APG-3288
  • 2/24/2026GenSci Advances PD-1 Agonist Into Phase 2b for Rheumatoid Arthritis
  • 2/24/2026Huadong Launches Head-to-Head Phase III Trial for Dual GLP-1/GIP Agoni...
  • 2/24/2026CDE Issues Guideline on Clinical Information for CAR-T Therapy Package...
  • 2/24/2026CDE Releases Q&A Document on Development Safety Update Reports
  • 2/24/2026CDE Issues Guidelines on Benefit-Risk Assessment Using Multi-Regional ...
  • 2/24/2026China Prepares to Implement Landmark Regulations for Clinical Research...
  • 2/24/2026Biokin's Iza-Bren Achieves Second Phase III Survival Success in China ...
  • 2/24/2026After 230% Deal Size Explosion, China Is No Longer the 'Bargain Baseme...
  • 2/21/2026Hansoh Pharma's Ameile Wins EU Approval for EGFR-Mutant Lung Cancer
  • 2/21/2026Leo Pharma Eyes China Comeback After Decade-Long Launch Drought
  • 2/20/2026CSPC's Long-Acting SYH2082 Clears FDA to Begin Clinical Trials
  • 2/20/2026China Biotech Kicks Off 2026 with $863 Million in January Raises
  • Page:4/822 Total number of articles:24634: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group